Key result
Women hospitalized for ACS had higher unadjusted in-hospital mortality than men (2.60% vs 1.50%, P<0.001), which was no longer significant after adjusting for clinical characteristics and treatments.
Why the study?
Coronary heart disease is a leading cause of mortality among women, but systematic evaluation of the quality of care and outcomes in women hospitalized for ACS remains lacking in China.
Does female sex impact in-hospital management and mortality in patients with acute coronary syndrome?
Observational (n=82,196)
Yes
Does female sex impact in-hospital management and mortality in patients with acute coronary syndrome?
Absolute Event Rate: 2.6% vs 1.5%
p-value: p=<0.001
Women hospitalized for ACS in China receive fewer evidence-based acute treatments and secondary prevention strategies than men, which largely explains their higher unadjusted in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Women with ACS in China receive fewer evidence-based therapies; extends evidence of sex disparities and supports targeted quality improvement.
Hao et al. (2019) conducted an observational in Acute Coronary Syndrome (n=82,196). Female sex vs. Male sex was evaluated on In-hospital mortality (p=<0.001). Women hospitalized for ACS had higher unadjusted in-hospital mortality than men (2.60% vs 1.50%, P<0.001), which was no longer significant after adjusting for clinical characteristics and treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: